ABSTRACT
Objectives To assess the association between blood circulating Vitamin D levels and colorectal cancer risk in the Asian population.
Design This is a systematic review and dose-response meta-analysis of observational studies that investigated the relationship between blood circulating Vitamin D levels and colorectal cancer risk in the Asian population.
Data Sources Relevant studies were identified through a literature search in MEDLINE, EMBASE, and Web of Science from January 1980 to 31 January 2019. Eligibility criteria: original studies published in peer-reviewed journals investigating the association between blood circulating Vitamin D levels and the risk of colorectal cancer and/or adenoma in Asian countries.
Data extraction and synthesis Two authors independently extracted data and assessed the quality of included studies. Study-specific ORs were pooled using a random-effects model. A dose-response meta-analysis was performed with generalized least squares regression. We applied the Newcastle-Ottawa Scale quality assessment to evaluate the quality of the selected studies.
Results The eight included studies encompassed a total of 2,916 cases and 6,678 controls. The pooled ORs of colorectal cancer for the highest versus lowest categories of blood circulating Vitamin D levels was 0.75 [95% CI, 0.58-0.97] up to 36.5 ng/mL in the Asian population. There was heterogeneity among the studies (I2=53.9%, Pheterogeneity=0.034). The dose-response meta-analysis indicated a significant linear relationship (Pnon-linearity=0.11). An increment of 16 ng/mL in blood circulating Vitamin D level corresponded to an OR of 0.79 [95% CI, 0.64-0.97].
Conclusions The results of this meta□analysis indicate that blood circulating Vitamin D level is associated with decreased risk of colorectal cancer in Asian countries. The dose-response meta-analysis shows that the strength of this association among the Asian population is similar to that among the Western population. Our study suggests that the Asian population should improve nutritional status and maintain a higher level of blood circulating Vitamin D.
Strengths and limitations of this study
Our study seeks to extend previous work by including a number of new studies and by distinguishing the Asian population explicitly.
The number of included studies is not sufficient to provide a robust estimate, so the results should be interpreted in the context of the limitations of the available data.
Heterogeneous definitions of blood circulating Vitamin D categories were used across studies. The variability in definitions could limit comparability between studies.
Our study included seven case-control studies; the study design implies that the measurement of blood circulating Vitamin D is measured in individuals already diagnosed with colorectal cancer. Results from case-control studies need to be interpreted cautiously because of the potential for reverse causation.
Time of blood sampling in relation to outcome ascertainment also varied among studies. Such cross-sectional measurements may not accurately reflect an individual’s Vitamin D status across time.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by National Key R&D Program of China (No. 2018YFC1315000/2018YFC1315003).
Author Declarations
All relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Not Applicable
Any clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.
Yes
Footnotes
Transparency declaration The Corresponding Authors affirm that this manuscript is an accurate account of the study proposed with no important aspects omitted, and that any discrepancies from the study as planned and registered will be explained upon the completion of the proposed study.
Ethical approval Ethics approval is not required for this study because it is a systematic review.
Details of funding This study was supported by the National Key R&D Program of China (No. 2018YFC1315000/2018YFC1315003).
Details of the role of the study sponsor Lin Zhang is supported by Peking Union Medical College Hospital 100 Elite Scholarship and Melbourne International Research Scholarship, The University of Melbourne. Peng Jia, Director of the International Initiative on Spatial Lifecourse Epidemiology (ISLE), thanks Lorentz Center, the Netherlands Organization for Scientific Research, the Royal Netherlands Academy of Arts and Sciences, the Chinese Center for Disease Control and Prevention, the West China School of Public Health in Sichuan University, for funding the ISLE and supporting ISLE’s research activities.
Conflict of interest The authors have declared that no competing interests exist.
Statement of independence of researchers form funders Not applicable.
Patient involvement No patients were involved in the design or analysis of this study.
Data sharing statement All data relevant to the study are included in the article or uploaded as supplementary information.
Data Availability
All data relevant to the study are included in the article or uploaded as supplementary information.